AI assistant
Sending…
RESMED INC — Director's Dealing 2015
Mar 11, 2015
30071_dirs_2015-03-11_39c835ec-11ff-4ce7-8f30-3c0f485cf8d7.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2015-03-09
Reporting Person: Reiser Anne (President - ResMed Europe)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-03-09 | ResMed Common Stock | M | 3000 | $17.30 | Acquired | 65198 | Direct |
| 2015-03-09 | ResMed Common Stock | S | 3000 | $66.75 | Disposed | 62198 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-03-09 | ResMed NQ Stock Options | $17.30 | M | 3000 | Disposed | 2015-11-24 | ResMed Common Stock (3000) | Direct |
More from RESMED INC
Regulatory Filings
2026
May 26
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 3
Director's Dealing
2026
Feb 10
Regulatory Filings
2026
Feb 9
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 6
Director's Dealing
2026
Feb 3
Interim / Quarterly Report
2026
Jan 30
Earnings Release
2026
Jan 29